The effect of the metabolic syndrome on the risk and outcome of coronary artery bypass graft surgery

Marius J Swart, Wihan H De Jager, Johann T Kemp, Paul J Nel, Sarel L Van Staden, Gina Joubert, Marius J Swart, Wihan H De Jager, Johann T Kemp, Paul J Nel, Sarel L Van Staden, Gina Joubert

Abstract

Background: The individual components of the metabolic syndrome are risk factors for coronary artery disease. The underlying pathophysiology of a low-grade inflammatory process postulates that the metabolic syndrome could compromise a procedure such as coronary artery bypass graft surgery (CABG) done on cardiopulmonary bypass (CPB).

Methods: From a single institution, 370 patients with the metabolic syndrome (IDF and ATP III criteria) and 503 patients without the metabolic syndrome were identified. The influence of the metabolic syndrome on the pre-operative core risk factors for CABG mortality as well as its effect on the mortality and major morbidity post surgery were investigated.

Results: Patients with the metabolic syndrome were operated on less urgently than those without the metabolic syndrome. The EuroSCORE was also lower in those with the metabolic syndrome. Patients with the metabolic syndrome required fewer units of homologous red blood cells, but stayed statistically longer in hospital.

Conclusions: In this surgical population the metabolic syndrome had no detrimental clinical effect on either the pre-operative risk factors or the outcome after CABG.

References

    1. Parsonet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation. 1989;79(suppl I):I–3. I–12.
    1. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.
    1. Van Straten AHM, Bramer S, Soliman Hamad MA. et al. Effect of body mass index on early and late mortality after coronary artery bypass grafting. Ann Thorac Surg. 2010;89:30–37.
    1. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40:418–423.
    1. Grover FL. The Society of Thoracic Surgeons National Database: Current status and future directions. Ann Thorac Surg. 1999;68:367–373.
    1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607.
    1. Bruce KD, Byrne CD. The metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J. 2009;85:614–621.
    1. Festa A, D’Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the Insulin Resistance Syndrome. Circulation. 2000;102:42–47.
    1. Santos A-C, Lopes C, Guimarães JT, Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Intl J Obesity. 2005;29:1452–1456.
    1. Echahidi N, Pibarot P, Després J-P. et al. Metabolic syndrome increases operative mortality in patients undergoing CABG. J Am Coll Cardiol. 2007;50:843–851.
    1. Shah B, Kumar N, Garg P. et al. Metabolic syndrome does not impact survival in patients treated for coronary artery disease. Coron Artery Dis. 2008;19:71–77.
    1. Domanski M. The metabolic syndrome. Clinical research: Atherosclerotic risk factors: Editorial comment. J Am Coll Cardiol. 2004;43:1396–1398.
    1. Cheng TO. Metabolic syndrome in China. Circulation. 2004;109:e180.
    1. Mollentze WF. Epidemiological aspects in South Africa. S Afr J Diabetes Vasc Dis. 2004;1:55–56.
    1. Zimmet P, Alberti G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: The rationale and the results. Diabetes Voice. 2005;50:31–33.
    1. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (ATPIII). J Am Med Assoc. 2001;285:2486–2497.
    1. Jones RH, Hannan EL, Hammermeister KE. et al. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. J Am Coll Cardiol. 1996;28:1478–1487.
    1. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470.
    1. Shoyer ALW, Coombs LP, Peterson ED. et al. The Society of Thoracic Surgeons: 30 day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856–1865.
    1. McNeill AM, Rosamond WD, Girmin CJ. et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care. 2005;28:385–390.
    1. Malik S, Wong ND, Franklin SS. et al. Impact of metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and all causes in United States adults. Circulation. 2004;110:1245–1250.
    1. Alberti KGMM, Eckel RH, Grundy SM. et al. Harmonizing the Metabolic Syndrome: A joint interim statement of the Internatinal Diabetes Federation Task Force on epidemiology and prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; Internatiol Atherosclerosis Society; and International Association for the study of Obesity. Circulatiom. 2009;120:1640–1645.
    1. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk. Arch Intern Med. 2002;162:2074–2079.
    1. Franco OH, Massaro JM, Civil J, Cobain MR, O’Malley B, D’Agostino RB. Trajectories of entering the metabolic syndrome: The Framingham Heart Study. Circulation. 2009;120:1943–1950.
    1. Tekumit H, Cenal AR, Polat A, Uzun K, Tataroglu C, Akinci E. Diagnostic value of hemoglobin A1c and fasting plasma glucose in coronary artery bypass grafting patients with undiagnosed diabetes mellitus. Ann Thorac Surg. 2010;89:1482–1489.
    1. Ranjith N, Pegoraro RJ, Naidoo DP, Esterhuizen TM. Metabolic syndrome in young Asian Indian patients with myocardial infartion. Cardiovasc J Afr. 2007;18:228–233.
    1. Engel AM, McDonough S, Smith JM. Does an obese body mass index affect hospital outcomes after coronary artery bypass graft surgery? Ann Thorac Surg. 2009;88:1793–1800.
    1. Anand SS, Qilong Y, Gerstein H. et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation. 2003;108:420–425.
    1. Kajimoto K, Miyauchi K, Kasai T. et al. Metabolic syndrome is an independent risk factor for stroke and acute renal failure after coronary artery bypass grafting. J Thorac and Cardiovasc Surg. 2009;137:658–663.
    1. Brackbill ML, Sytsma CS, Sykes K. Perioperative outcomes of coronary artery bypass grafting: Effects of metabolic syndrome and patient’s sex. Am J Crit Care. 2009;18:468–473.
    1. Simmons RK, Alberti KGMM, Gale EAM. et al. The metabolic syndrome: Useful concept or clinical tool? Diabetologia. 2010;53:600–605.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa